Scientific Session: Prostate Snap Orals

Friday, June 25, 2021

12:10 PM - 1:10 PM

12:10 pm - 12:15 PM

Combination EBRT and Brachytherapy Boost is Associated with Improved Overall Survival Relative to Definitive Brachytherapy in Unfavorable Intermediate-Risk Prostate Cancer

Neal Andruska, MD

12:15 PM - 12:20PM

Patient-Reported Urinary Symptoms after Prostate Brachytherapy - Is There a Relationship with Bladder Neck Dose?

Sean Koerner, MD

12:20 PM - 12:25 PM

Interobserver Variability of Target and OAR Delineation in MRI-Based Prostate Brachytherapy across Two Anatomical Pulse Sequences

Jeremiah Sanders, PhD

12:25 PM - 12:30 PM

High Dose Rate Monotherapy in Localized Prostate Cancer: Efficacy Results and Prostate-Specific Antigen Kinetics

Miren Gaztañaga, MD

12:30 pm - 12:35 PM

Permanent Interstitial LDR-Brachytherapy for Prostate Cancer Implementing Prostatic Artery Embolization

Hathal Haddad, MD

12:35 PM - 12:40 PM

After ASCENDE-RT: Outcomes of Androgen Deprivation, External Beam Radiation and LDR Brachytherapy Boost for High-Tier Intermediate and High Risk Prostate Cancer

Jack Zheng

12:40 PM - 12:45 PM

Does the Sequence of High-Dose Rate Brachytherapy Boost and IMRT for Prostate Cancer Impact Early Disease and Toxicity Outcomes? Results from a Single Institution Analysis

Amit Roy, MD

12:45 PM - 12:59 PM

Feasibility and Efficacy of Bladder Neck Urethral Sparing Technique in Prostate Brachytherapy

Ryan Smith, MD

12:50 PM - 12:55 PM

Are the Risk Groups Used for External Beam Treatment of Prostate Cancer Appropriate for LDR Brachytherapy Treatment?

Howard Thames, PhD

12:45 PM - 12:50 PM

Effect of Short-Term Corticosteroid Usage on Acute Urinary Toxicity Following Cs-131 Prostate Brachytherapy

Andrew Keller, MD

12:55 PM - 1:00 PM

Low Dose Rate Brachytherapy before or after Transurethral Resection of the Prostate

Vishal Dhere, MD

1:00 PM - 1:05 PM

Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy

Mark Corkum, MD